Vitamin K2 — Research Evidence
The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.
The research on Vitamin K2 spans several health domains, with the strongest and most consistent evidence focused on bone health, particularly in postmenopausal women. Multiple meta-analyses, systematic reviews, and RCTs collectively suggest that Vitamin K2 — especially in the form of menaquinone-7 (MK-7) — may help reduce bone loss, improve bone quality, and support skeletal health, often with greater effect when combined with Vitamin D and calcium. There is also emerging evidence for cardiovascular benefits, including improvements in arterial stiffness, though this area is less established. More preliminary evidence exists for applications in dermatology and symptom management such as nocturnal leg cramps.
Key findings
- ✓Meta-analyses and systematic reviews support Vitamin K2 supplementation for reducing bone loss and improving bone mineral density in postmenopausal women, particularly when combined with Vitamin D.
- ✓A 3-year RCT found that low-dose MK-7 supplementation helped decrease bone loss in healthy postmenopausal women, suggesting benefits even at modest doses over extended periods.
- ✓RCTs in both healthy postmenopausal women and chronic hemodialysis patients found improvements in arterial stiffness with MK-7 supplementation, pointing to potential cardiovascular benefits.
- ✓A randomized clinical trial investigated Vitamin K2 for managing nocturnal leg cramps, suggesting possible benefits beyond bone and cardiovascular health, though this is a less-studied application.
- ✓The combination of Vitamin K and Vitamin D appears to have a synergistic effect on bone quality, supported by meta-analyses of randomized controlled trials.
Evidence gaps
- ?Most studies focus on postmenopausal women or specific patient populations such as hemodialysis patients, leaving gaps in evidence for men, younger adults, and diverse demographics.
- ?Optimal dosing, duration, and form of Vitamin K2 (e.g., MK-4 vs. MK-7) have not been firmly established, and no separate Recommended Daily Intake for K2 distinct from K1 has been widely adopted.
- ?Evidence for applications outside bone and cardiovascular health — such as dermatology, leg cramps, and aortic valve calcification — is limited to single or small trials and requires larger, well-powered studies before conclusions can be drawn.
Safety summary
Vitamin K2 supplementation appears to be well-tolerated in the populations studied, with no major safety concerns flagged across the reviewed trials. However, individuals on anticoagulant medications such as warfarin should exercise caution, as Vitamin K can interfere with clotting-related drug mechanisms.
Studies (20)
Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials.
The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials.
The effect of vitamin K supplementation on cardiovascular risk factors: a systematic review and meta-analysis.
The effect of vitamin K supplementation on cardiovascular risk factors: a systematic review and meta-analysis.
[Vitamin K2].
[Vitamin K2].
Vitamin K and osteoporosis: Myth or reality?
Vitamin K and osteoporosis: Myth or reality?
Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial.
Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial.
Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial.
Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial.
Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial.
Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial.
Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health.
Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health.
MK-7 and Its Effects on Bone Quality and Strength.
MK-7 and Its Effects on Bone Quality and Strength.
Vitamin K in dermatology.
Vitamin K in dermatology.
Vitamin K and bone health.
Vitamin K and bone health.
Vitamin K2 Needs an RDI Separate from Vitamin K1.
Vitamin K2 Needs an RDI Separate from Vitamin K1.
Integrative approaches to perimenopause.
Integrative approaches to perimenopause.
Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease.
Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease.
Effect of vitamin K2 on type 2 diabetes mellitus: A review.
Effect of vitamin K2 on type 2 diabetes mellitus: A review.
Vitamin K Nutritional Status and Disease Risk - A Mendelian Randomization Analysis.
Vitamin K Nutritional Status and Disease Risk - A Mendelian Randomization Analysis.
Nutritional Support of Chronic Obstructive Pulmonary Disease.
Nutritional Support of Chronic Obstructive Pulmonary Disease.